Actoverco Pharmaceutical Company
Actoverco Pharmaceutical Company is a private Iranian pharmaceutical manufacturer founded in 1973, headquartered in Tehran and operating main factories in Karaj. It produces more than 320 medicines across 15 therapeutic areas, including products made under licence for Merck KGaA and Krka, and has biopharmaceutical and oncology interests. It is a material domestic manufacturing partner in Iran’s healthcare supply chain.
Operations & footprint
Products and services
Actoverco manufactures, imports, licenses, markets and distributes pharmaceutical products across therapeutic areas including diabetes, cardiovascular disease, neurology, respiratory disease, gastroenterology, women's health, infectious disease, nephrology and urology, oncology, specialty medicines, branded generics, biosimilars and licensed products. The wider Actover pharmaceutical group includes multiple manufacturing entities and biotechnology, oncology, supplement and pharmaceutical businesses.
Operations and assets
Actoverco’s main factories are located in Baharestan Industrial Town, Karaj, Alborz Province. The company combines domestic pharmaceutical manufacturing with under-licence production, while its wider operations include biopharmaceutical and oncology activity.
Geographic footprint
Headquarters in Tehran and main manufacturing operations in Karaj, Alborz Province, Iran.
Ownership & group structure
Ownership
Private joint-stock company.
Subsidiaries and group companies
Actero Pharma is a joint venture focused on high-potency oncology medicines. Actover Biotech is the group’s biopharmaceutical and biosimilar investment platform.
Reported scale
Employees: Over 2,000 employees.
Commercial and investment relevance
Actoverco is relevant for investors assessing Iran's branded-generic market, licensed pharmaceutical manufacturing, specialty medicines, biosimilars, technology transfer and private pharmaceutical groups. Due diligence should verify group-company boundaries, product registrations, manufacturing sites and licenses, GMP compliance, licensing and supply agreements with foreign partners, API sourcing, FX allocation, distribution arrangements, pharmacovigilance systems, product recalls, export markets, IP obligations and exposure to healthcare price regulation and import restrictions. The company is a relevant local manufacturing and commercialisation partner for pharmaceutical principals, ingredient suppliers and healthcare buyers seeking access to Iran’s medicines market. Under-licence production for Merck KGaA and Krka demonstrates experience with licensed-product manufacturing arrangements.
Constraints, risk & compliance
Key risks and constraints
Commercial performance depends on reliable active pharmaceutical ingredient supply, regulatory product approvals and continuity of licensed-product and technology-transfer arrangements. Its broad medicines portfolio also requires sustained manufacturing quality and pharmacovigilance controls.
Sanctions and compliance considerations
Cross-border procurement, licensing and technology-transfer relationships require transaction-specific sanctions and export-control screening, particularly for pharmaceutical inputs, equipment and foreign counterparties.
Need more than a public profile?
Ask Hormuz to investigate, verify or act locally around Actoverco Pharmaceutical Company. Tell us exactly what you need.
Connected Intelligence
Relevant geography, industry, market and execution context for this profile.
Frequently asked questions
Direct answers to the questions most likely to arise when reviewing this profile.
What does Actoverco Pharmaceutical Company do?
Actoverco manufactures pharmaceutical products across 15 therapeutic areas, with a portfolio of more than 320 products. Its activities include under-licence production for Merck KGaA and Krka, alongside biopharmaceutical and biosimilar investment.
Where are Actoverco’s operations located?
Actoverco is headquartered in Tehran. Its main factories are in Baharestan Industrial Town, Karaj, Alborz Province, Iran.
Is Actoverco a listed company?
No. Actoverco Pharmaceutical Company is registered as a private joint-stock company.
What specialist pharmaceutical activities are associated with the Actover group?
The group includes Actero Pharma, a joint venture focused on high-potency oncology medicines, and Actover Biotech, which supports biopharmaceutical and biosimilar activity.